Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Proteomics | 31 | 2025 | 197 | 6.080 |
Why?
|
| Mass Spectrometry | 27 | 2026 | 199 | 5.840 |
Why?
|
| Tandem Mass Spectrometry | 20 | 2026 | 117 | 4.900 |
Why?
|
| Proteins | 13 | 2026 | 254 | 3.760 |
Why?
|
| Proteome | 10 | 2025 | 81 | 2.850 |
Why?
|
| Antibodies, Monoclonal | 10 | 2024 | 336 | 2.030 |
Why?
|
| Chromatography, Liquid | 12 | 2025 | 79 | 1.670 |
Why?
|
| Protons | 2 | 2024 | 54 | 1.480 |
Why?
|
| Protein Processing, Post-Translational | 16 | 2025 | 109 | 1.460 |
Why?
|
| Ions | 5 | 2024 | 19 | 1.270 |
Why?
|
| Software | 6 | 2026 | 127 | 1.190 |
Why?
|
| Immunoglobulin G | 5 | 2018 | 272 | 1.030 |
Why?
|
| Leukocytes, Mononuclear | 3 | 2024 | 82 | 1.000 |
Why?
|
| Specimen Handling | 2 | 2025 | 33 | 0.950 |
Why?
|
| Sequence Analysis, Protein | 3 | 2024 | 15 | 0.910 |
Why?
|
| Serum Albumin, Human | 1 | 2024 | 1 | 0.890 |
Why?
|
| Disulfides | 1 | 2024 | 34 | 0.880 |
Why?
|
| Immunoconjugates | 1 | 2024 | 21 | 0.860 |
Why?
|
| Amino Acid Sequence | 12 | 2024 | 697 | 0.820 |
Why?
|
| Ion Mobility Spectrometry | 1 | 2023 | 1 | 0.810 |
Why?
|
| Peptides | 8 | 2021 | 297 | 0.750 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2019 | 72 | 0.730 |
Why?
|
| Ultraviolet Rays | 3 | 2019 | 40 | 0.680 |
Why?
|
| Trastuzumab | 2 | 2018 | 12 | 0.670 |
Why?
|
| Electrons | 3 | 2017 | 27 | 0.630 |
Why?
|
| Humans | 34 | 2026 | 28995 | 0.600 |
Why?
|
| Saccharomyces cerevisiae Proteins | 3 | 2025 | 115 | 0.590 |
Why?
|
| Carbonic Anhydrases | 2 | 2019 | 6 | 0.570 |
Why?
|
| Rituximab | 1 | 2018 | 64 | 0.560 |
Why?
|
| Peptide Fragments | 3 | 2017 | 202 | 0.550 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 42 | 0.540 |
Why?
|
| Bacterial Proteins | 2 | 2019 | 499 | 0.530 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 3 | 2025 | 62 | 0.530 |
Why?
|
| Adalimumab | 1 | 2017 | 4 | 0.520 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2026 | 6 | 0.490 |
Why?
|
| Cysteine | 3 | 2025 | 68 | 0.470 |
Why?
|
| HSP70 Heat-Shock Proteins | 3 | 2025 | 45 | 0.470 |
Why?
|
| Saccharomyces cerevisiae | 3 | 2025 | 178 | 0.440 |
Why?
|
| Myoglobin | 3 | 2026 | 34 | 0.430 |
Why?
|
| Protein Isoforms | 5 | 2022 | 119 | 0.430 |
Why?
|
| Transferrins | 1 | 2013 | 1 | 0.410 |
Why?
|
| Photons | 3 | 2024 | 27 | 0.410 |
Why?
|
| Fourier Analysis | 6 | 2019 | 31 | 0.390 |
Why?
|
| Animals | 15 | 2026 | 10713 | 0.370 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 4 | 2019 | 72 | 0.360 |
Why?
|
| Fungal Proteins | 3 | 2019 | 84 | 0.350 |
Why?
|
| Substance P | 1 | 2010 | 6 | 0.340 |
Why?
|
| Transglutaminases | 1 | 2010 | 8 | 0.340 |
Why?
|
| Amides | 1 | 2010 | 19 | 0.330 |
Why?
|
| Apolipoprotein A-I | 2 | 2021 | 38 | 0.320 |
Why?
|
| Molecular Sequence Data | 5 | 2016 | 1056 | 0.310 |
Why?
|
| Databases, Protein | 2 | 2022 | 22 | 0.300 |
Why?
|
| Immunoglobulin Heavy Chains | 2 | 2019 | 10 | 0.300 |
Why?
|
| Immunoglobulin Light Chains | 2 | 2019 | 7 | 0.300 |
Why?
|
| Protein Interaction Mapping | 3 | 2021 | 34 | 0.280 |
Why?
|
| Colorectal Neoplasms | 2 | 2021 | 142 | 0.280 |
Why?
|
| Histones | 3 | 2019 | 96 | 0.270 |
Why?
|
| Histone-Lysine N-Methyltransferase | 2 | 2019 | 6 | 0.270 |
Why?
|
| Neoplasm Proteins | 2 | 2019 | 123 | 0.270 |
Why?
|
| Fibroblasts | 2 | 2019 | 160 | 0.270 |
Why?
|
| Multiple Myeloma | 2 | 2019 | 39 | 0.260 |
Why?
|
| HSP90 Heat-Shock Proteins | 2 | 2024 | 61 | 0.260 |
Why?
|
| Repressor Proteins | 2 | 2019 | 119 | 0.250 |
Why?
|
| Data Mining | 2 | 2017 | 17 | 0.250 |
Why?
|
| Protein Multimerization | 2 | 2017 | 57 | 0.250 |
Why?
|
| Alcohol Dehydrogenase | 1 | 2026 | 7 | 0.240 |
Why?
|
| Heat-Shock Response | 1 | 2025 | 13 | 0.240 |
Why?
|
| Infrared Rays | 1 | 2026 | 25 | 0.240 |
Why?
|
| Methanol | 1 | 2025 | 15 | 0.240 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2025 | 19 | 0.240 |
Why?
|
| Pyruvate Kinase | 1 | 2026 | 13 | 0.240 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2025 | 27 | 0.230 |
Why?
|
| Antibodies | 1 | 2026 | 125 | 0.230 |
Why?
|
| Electron Transport | 3 | 2014 | 31 | 0.230 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2024 | 3 | 0.220 |
Why?
|
| Proteostasis | 1 | 2024 | 9 | 0.220 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 111 | 0.220 |
Why?
|
| Aspartic Acid Endopeptidases | 2 | 2014 | 12 | 0.210 |
Why?
|
| Aspartic Acid | 2 | 2021 | 52 | 0.210 |
Why?
|
| Proteolysis | 3 | 2018 | 59 | 0.200 |
Why?
|
| Chromatography, High Pressure Liquid | 3 | 2018 | 131 | 0.190 |
Why?
|
| Blood Cells | 1 | 2022 | 10 | 0.180 |
Why?
|
| Biomarkers | 1 | 2025 | 782 | 0.180 |
Why?
|
| Apolipoprotein A-II | 1 | 2021 | 2 | 0.180 |
Why?
|
| Mice | 6 | 2025 | 4814 | 0.180 |
Why?
|
| Blood Proteins | 1 | 2022 | 68 | 0.180 |
Why?
|
| Bone Marrow Cells | 1 | 2022 | 81 | 0.180 |
Why?
|
| NAV1.8 Voltage-Gated Sodium Channel | 1 | 2021 | 3 | 0.180 |
Why?
|
| Scorpion Venoms | 1 | 2021 | 2 | 0.180 |
Why?
|
| Voltage-Gated Sodium Channels | 1 | 2021 | 4 | 0.180 |
Why?
|
| Sodium Channel Blockers | 1 | 2021 | 11 | 0.180 |
Why?
|
| Scorpions | 1 | 2021 | 9 | 0.170 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 788 | 0.170 |
Why?
|
| Signal Transduction | 3 | 2025 | 1469 | 0.170 |
Why?
|
| Cellular Senescence | 2 | 2020 | 141 | 0.170 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 92 | 0.160 |
Why?
|
| Escherichia coli | 1 | 2023 | 339 | 0.160 |
Why?
|
| Chromatography, Reverse-Phase | 2 | 2016 | 10 | 0.160 |
Why?
|
| Ubiquitin | 1 | 2019 | 24 | 0.160 |
Why?
|
| Myocytes, Cardiac | 1 | 2019 | 64 | 0.150 |
Why?
|
| Poly ADP Ribosylation | 1 | 2019 | 2 | 0.150 |
Why?
|
| Cells, Cultured | 2 | 2019 | 1022 | 0.150 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2019 | 8 | 0.150 |
Why?
|
| Benchmarking | 1 | 2019 | 33 | 0.150 |
Why?
|
| Signal-To-Noise Ratio | 3 | 2014 | 16 | 0.150 |
Why?
|
| Chromatin | 1 | 2019 | 76 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2021 | 472 | 0.140 |
Why?
|
| Lipoproteins, HDL | 1 | 2018 | 41 | 0.140 |
Why?
|
| Point Mutation | 1 | 2018 | 61 | 0.140 |
Why?
|
| Mutation, Missense | 1 | 2018 | 71 | 0.140 |
Why?
|
| Cell Line, Tumor | 5 | 2021 | 1351 | 0.130 |
Why?
|
| Mutation | 1 | 2021 | 869 | 0.130 |
Why?
|
| Cardiovascular Diseases | 1 | 2021 | 381 | 0.130 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 54 | 0.130 |
Why?
|
| Elapidae | 1 | 2016 | 1 | 0.120 |
Why?
|
| Elapid Venoms | 1 | 2016 | 3 | 0.120 |
Why?
|
| Models, Molecular | 2 | 2018 | 453 | 0.120 |
Why?
|
| Candida albicans | 2 | 2014 | 49 | 0.120 |
Why?
|
| Protein Conformation | 4 | 2019 | 259 | 0.120 |
Why?
|
| Cattle | 2 | 2016 | 389 | 0.120 |
Why?
|
| Computational Biology | 1 | 2017 | 156 | 0.120 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 22 | 0.110 |
Why?
|
| Adenosine Triphosphatases | 2 | 2025 | 50 | 0.110 |
Why?
|
| Streptococcus pyogenes | 1 | 2014 | 32 | 0.100 |
Why?
|
| Protein Denaturation | 3 | 2019 | 28 | 0.100 |
Why?
|
| Equipment Design | 1 | 2013 | 218 | 0.100 |
Why?
|
| Oxidation-Reduction | 1 | 2013 | 381 | 0.090 |
Why?
|
| Structure-Activity Relationship | 1 | 2012 | 209 | 0.090 |
Why?
|
| Polysaccharides | 1 | 2012 | 65 | 0.090 |
Why?
|
| Serine Endopeptidases | 1 | 2010 | 19 | 0.080 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2010 | 36 | 0.080 |
Why?
|
| Guinea Pigs | 1 | 2010 | 73 | 0.080 |
Why?
|
| Glutamine | 1 | 2010 | 32 | 0.080 |
Why?
|
| Cell Proliferation | 2 | 2025 | 825 | 0.080 |
Why?
|
| Recombinant Proteins | 3 | 2018 | 417 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2010 | 121 | 0.080 |
Why?
|
| Complementarity Determining Regions | 2 | 2020 | 11 | 0.070 |
Why?
|
| Protein Binding | 2 | 2022 | 667 | 0.070 |
Why?
|
| Liver | 1 | 2010 | 471 | 0.070 |
Why?
|
| Amino Acids | 2 | 2018 | 85 | 0.060 |
Why?
|
| Methylation | 2 | 2018 | 24 | 0.060 |
Why?
|
| Automation | 1 | 2026 | 21 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2025 | 27 | 0.060 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2019 | 55 | 0.060 |
Why?
|
| Molecular Weight | 2 | 2018 | 122 | 0.060 |
Why?
|
| Protein Prenylation | 1 | 2025 | 1 | 0.060 |
Why?
|
| Acetylation | 1 | 2024 | 41 | 0.060 |
Why?
|
| Phosphorylation | 1 | 2025 | 585 | 0.050 |
Why?
|
| Cell Line | 2 | 2017 | 701 | 0.050 |
Why?
|
| Molecular Chaperones | 1 | 2022 | 50 | 0.050 |
Why?
|
| Plasma | 1 | 2022 | 32 | 0.050 |
Why?
|
| Alternative Splicing | 1 | 2022 | 48 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2022 | 53 | 0.040 |
Why?
|
| Argininosuccinate Synthase | 1 | 2021 | 1 | 0.040 |
Why?
|
| Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor | 1 | 2021 | 1 | 0.040 |
Why?
|
| NAV1.7 Voltage-Gated Sodium Channel | 1 | 2021 | 1 | 0.040 |
Why?
|
| Plant Bark | 1 | 2021 | 2 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2021 | 5 | 0.040 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (GTP) | 1 | 2021 | 6 | 0.040 |
Why?
|
| Gene Ontology | 1 | 2021 | 14 | 0.040 |
Why?
|
| Arizona | 1 | 2021 | 38 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2021 | 58 | 0.040 |
Why?
|
| Receptor, EphA2 | 1 | 2021 | 2 | 0.040 |
Why?
|
| Protein Interaction Maps | 1 | 2021 | 11 | 0.040 |
Why?
|
| Liver Transplantation | 1 | 2022 | 56 | 0.040 |
Why?
|
| Triglycerides | 1 | 2021 | 123 | 0.040 |
Why?
|
| Carcinogenesis | 1 | 2021 | 81 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 87 | 0.040 |
Why?
|
| T-Lymphocytes | 1 | 2022 | 285 | 0.040 |
Why?
|
| Protein Kinases | 1 | 2021 | 155 | 0.040 |
Why?
|
| B-Lymphocytes | 1 | 2022 | 286 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 27 | 0.040 |
Why?
|
| Phlebotomy | 1 | 2019 | 3 | 0.040 |
Why?
|
| Gene Expression Profiling | 1 | 2021 | 465 | 0.040 |
Why?
|
| Complex Mixtures | 1 | 2019 | 12 | 0.040 |
Why?
|
| Pain | 1 | 2021 | 258 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2021 | 285 | 0.040 |
Why?
|
| Horses | 1 | 2018 | 37 | 0.040 |
Why?
|
| Indicators and Reagents | 1 | 2018 | 26 | 0.040 |
Why?
|
| Nitrosation | 1 | 2018 | 4 | 0.040 |
Why?
|
| Prenylation | 1 | 2018 | 3 | 0.040 |
Why?
|
| Thiocyanates | 1 | 2018 | 19 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2019 | 169 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2018 | 133 | 0.030 |
Why?
|
| Sequence Alignment | 1 | 2018 | 112 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2018 | 245 | 0.030 |
Why?
|
| Biological Transport | 1 | 2018 | 128 | 0.030 |
Why?
|
| Protein Subunits | 1 | 2017 | 44 | 0.030 |
Why?
|
| Phenotype | 1 | 2020 | 687 | 0.030 |
Why?
|
| Chemical Fractionation | 1 | 2017 | 9 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2017 | 14 | 0.030 |
Why?
|
| Gases | 1 | 2017 | 23 | 0.030 |
Why?
|
| Precision Medicine | 1 | 2018 | 82 | 0.030 |
Why?
|
| Web Browser | 1 | 2017 | 4 | 0.030 |
Why?
|
| Porosity | 1 | 2016 | 38 | 0.030 |
Why?
|
| Cholesterol | 1 | 2018 | 204 | 0.030 |
Why?
|
| L-Amino Acid Oxidase | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2018 | 268 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2017 | 58 | 0.030 |
Why?
|
| Models, Chemical | 1 | 2016 | 90 | 0.030 |
Why?
|
| Obesity | 1 | 2021 | 702 | 0.030 |
Why?
|
| Lysine | 1 | 2015 | 78 | 0.030 |
Why?
|
| Binding Sites | 1 | 2016 | 355 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 677 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 238 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2015 | 247 | 0.030 |
Why?
|
| Male | 2 | 2021 | 13983 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2015 | 148 | 0.030 |
Why?
|
| Phosphopeptides | 1 | 2013 | 14 | 0.030 |
Why?
|
| Female | 2 | 2021 | 15688 | 0.020 |
Why?
|
| Algorithms | 1 | 2016 | 431 | 0.020 |
Why?
|
| Static Electricity | 1 | 2012 | 35 | 0.020 |
Why?
|
| Glycopeptides | 1 | 2012 | 3 | 0.020 |
Why?
|
| Pressure | 1 | 2012 | 91 | 0.020 |
Why?
|
| Glycosylation | 1 | 2012 | 70 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 202 | 0.020 |
Why?
|
| Middle Aged | 1 | 2021 | 7428 | 0.020 |
Why?
|
| Adult | 1 | 2021 | 8048 | 0.020 |
Why?
|
| Aged | 1 | 2018 | 5608 | 0.020 |
Why?
|